Son veriler ışığında kalp dışı cerrahi öncesi kardiyak değerlendirme

Amaç: Kalp dışı cerrahi sonrası, kardiyak komplikasyonlar perioperatif morbidite ve mortalitenin önde gelen nedenidir. Hastaların sistematik olarak preoperatif değerlendirilmesi, perioperatif kardiyak olayları ve maliyeti azaltır. Ana bulgular: Hastayı takip eden doktor, kardiyolog, cerrah ve anestezistin birlikte çalışması, tedavinin gerçekçi, uygun ve optimal olmasını sağlayarak, perioperatif kardiyovasküler riski düşürür. Sonuç: Klinik olarak düşük risklive fonksiyonel kapasitesi iyi olan hastalarda, düşük ve orta riskli cerrahi müdahaleler mükemmel bir prognozla, ek bir değerlendirme gerekmeksizin yapılabilir. Ayrıca daha önceden revaskülarize edilen stabil hastalar da güvenle opere edilebilir.

Cardiac assessment in patient before noncardiac surgery and review of literature

Objective: Cardiac complications are the leading cause of perioperative morbidity and mortality following noncardiac surgery. A strategic preoperative evaluation holds the potential to reduce perioperative cardiac events and healthcare costs. Main findings: A close working relationship between the primary care physician, cardiologist, surgeon and anesthesiologist will facilitate rational, tailored and optimized management decisions that constitute our best opportunity to reduce perioperative cardiovascular risk. Conclusion: Patients with low clinical risk factors and good functional status, undergoing a low or intermediate risk surgery, have an excellent prognosis and may proceed to surgery without further delay. In addition, stable patients who have previously undergone coronary revascularization may also safely undergo surgery.

Kaynakça

1. Fleisher LA, Eagle KA. Anesthesia and noncardiac surgery in patients with heart disease. In: Braunwald E, Zipes DP, Libby P, Bonow RO, editors. Braunwald’s Heart Disease: A Textbook Cardiovascular Medicine. 7th ed. Philadephia: Elsevier Saunders; 2005. p.2021-35.

2. Crawford MH. Perioperative evaluation of the cardiac patient. In: Crawford MH, DiMarco JP, editor. Cardiology. USA:Mosby; 2002. p.18.1-9.

3. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9.

4. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al. ACC/AHA Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2007;116:418-499.

5. Debabrata M, Eagle KA. Perioperative evaluation and management of patients with known or suspected cardiovascular disease who undergo noncardiac surgery. In: Fuster V, Alexander RW, O’Rourke RA, editors. Hurst’s The Heart. 11th ed. The McGraw-Hill;2004. p:2037-60.

6. Fleisher LA, Eagle KA. Clinical practise: lowering cardiac risk in non cardiac surgery. N Engl J Med 2001;345:1677-82.

7. Schein OD, Katz J, Bass EB, Tielsch JM, Lubomski LH, Feldman MA, et al. The value of routine preoperatif medical testing before cataract surgery. Am J Ophtalmol 2000;129:701.

8. Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 2005;95:755-7.

9. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Periopertive beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349-61.

10. Aronow WS, Ahn C. Incidence of heart failure in 2737 older persons with and without diabetes mellitus. Chest 1999;115:867-8.

11. Zeigler DW, Wright JG, Choban PS, Flancbaum L. A prospective randomised trial of perioperative “ optimization” of cardiac function in patients undergoing elective peripheral vascular surgery. Surgery 1997;122:584-92.

12. Thompson RC, Liberthson RR, Lowestein E. Perioperative anesthetic risc of noncardiac surgery in patients hypertrophic obstructive cardiomyopathy. JAMA 1985;254:2419-21.

13. Türk Kardiyoloji Derneği. İnfektif Endokardit Tanı, Korunma ve Tedavi Kılavuzu, 2004.

14. Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50.

15. Christ M, SharkovaY, Geldner G, Maisch B. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing aortic stenosis.Chest2005;128:2944-53.

16. Rahimtola SL. Catheter balloon valvuloplasty of aortic and mitral stenosis in adults. Circulation 1987;75:895-901.

17. Shaikh S, Cohen MC, Eagle KA. Role of the cardiology consultant. In: Topol EJ, editor. Textbook of cardiovascular medicine. Second ed. Philadelphia: Lippincot Williams&Wilkins; 2002.p.935-56.

18. Wiklund RA, RosenbaumS. HMedical Progress: Anesthesiology-Second of Two Parts.N Engl J Med 1997;337:1132-41.

19. Spandorfer JM, Lynch S, Weitz HH, Fertel S, Merli GJ. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999;84:478-80.

20. Tinmouth AH, Morrow BH, Cruickshank MK, Moore PM, Kovacs MJ. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother 2001;35:669-74.

21. Gohlke-Bärwolf C, Zentrum H, Krozingen B. Anticoagulation in valvar heart disease:New aspects and management duringnon-cardiac surgery. Heart 2000;84:567-72.

22. Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: A practical guide for clinicians. Thrombosis Research 2003;108:3-13.

23. Swerdlow CD, Winkle RA, Mason JV. Prognostic significance of the number of induced ventricular complexes during assessment of theraphy for ventricular tachyarrhythmias. Circulation 1993;68:400-05.

24. Cook PT, Davies MJ, Cronin KD, Moran P. A prospective randomised trial comparing spinal anaesthesia using hyperbaric cinchocaine with general anaesthesia for lower limb vascular surgery. Anaesth Intensive Care 1986;14:373-80.

25. Christopherson R, Beattie C, Frank SM, Norris EJ, Meinert CL, Gottlieb SO, et al. Perioperative morbidity in patients randomised to epidural or general anaesthesia for lower extremity vascular surgery. Perioperative Ischemia Randomized Anasthesia Trial Study Group. Anaesthesiology 1993;79:422-34.

26. Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 2003;48:233-7.

27. Collet JP, Himbet F, Steg PG. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 2000;76:257-8.

28. Manning BJ, O'Brien N, Aravindan S, Cahill RA, McGreal G, Redmond HP. The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury 2004;35:121-4.

29. Patrono C, Coller B, Dalen JE, Fitzgerald GA, Fuster V, Gent M, et al. Platelet-active drugs: The relationships among dose, effectiveness, and side effects. Chest 2001;119:39-63.

30. Palareti G, Legnani C. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 1996;30:300-13.

Kaynak Göster